PRESS RELEASE published on 10/17/2023 at 14:00, 1 year 1 month ago New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
PRESS RELEASE published on 10/12/2023 at 14:00, 1 year 1 month ago Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
PRESS RELEASE published on 10/10/2023 at 14:00, 1 year 1 month ago Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
PRESS RELEASE published on 10/04/2023 at 14:00, 1 year 1 month ago Salix Pharmaceuticals Partners with Bellamy Young
PRESS RELEASE published on 09/29/2023 at 16:15, 1 year 1 month ago Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
PRESS RELEASE published on 09/21/2023 at 14:00, 1 year 2 months ago League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease
PRESS RELEASE published on 09/18/2023 at 23:45, 1 year 2 months ago Bausch Health Announces CFO Transition Plan
PRESS RELEASE published on 09/12/2023 at 14:00, 1 year 2 months ago New Bausch Health Treatment PrUCERIS(R) (budesonide) Aerosol Foam Now Available Across Canada to Treat Mild to Moderate Distal Ulcerative Colitis in Adults
PRESS RELEASE published on 09/12/2023 at 14:00, 1 year 2 months ago Le nouveau traitement de Bausch Health PrUCERIS(R) (budésonide), en mousse en aérosol pour traiter la colite ulcéreuse distale légère à modérée chez l’adulte, est maintenant offert partout au Canada
PRESS RELEASE published on 09/11/2023 at 14:00, 1 year 2 months ago Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
Published on 11/22/2024 at 09:00, 3 hours 55 minutes ago Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 12 hours 55 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 14 hours 50 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 15 hours 5 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 16 hours 40 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/22/2024 at 11:54, 1 hour ago PIERER Mobility denies media reports about Mark Mateschitz's participation in PIERER Mobility and KTM
Published on 11/22/2024 at 11:45, 1 hour 10 minutes ago How 5G Transforms Life: A Foreigner's Journey Through East China's Digital Revolution
Published on 11/22/2024 at 11:21, 1 hour 34 minutes ago Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 11:06, 1 hour 49 minutes ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 06:58, 1 day 5 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 5 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 5 hours ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 16 hours ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 17 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
